In our previous study, we observed that phosphorylation of AKT and ERK was inhibited by gefitinib in both gefitinib‐sensitive and ‐insensitive wild‐type EGFR NSCLC cell lines. This evidence concerns the gene EGFR and non-small cell lung carcinoma.